Metolazone

In the US, Metolazone (metolazone systemic) is a member of the drug class thiazide diuretics and is used to treat Edema and High Blood Pressure.

US matches:

• Metolazone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C03BA08

CAS registry number (Chemical Abstracts Service)

0017560-51-9

Chemical Formula

C16-H16-Cl-N3-O3-S

Molecular Weight

365

Therapeutic Category

Diuretic agent

Chemical Name

6-Quinazolinesulfonamide, 7-chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-

Foreign Names

• Metolazonum (Latin)
• Metolazon (German)
• Métolazone (French)
• Metolazona (Spanish)

Generic Names

• Metolazone (OS: JAN, USAN, DCIT, BAN)
• Métolazone (OS: DCF)
• SR 720-22 (IS)
• Metolazone (PH: Ph. Eur. 6, USP 32, BP 2010)
• Metolazonum (PH: Ph. Eur. 6)

Brand Names

• Diulo
  Pfizer, Portugal



• Metenix
  IFET, Greece; Sanofi-Aventis, United Kingdom



• Metolaz
  Centaur, India



• Metolazon Galepharm
  Galepharm, Switzerland



• Metolazone
  Mylan, United States; Sandoz, United States



• Metoz
  Centaur, India



• Mykrox
  Orient Europharma, Taiwan



• Pavedal
  Pharma Investi, Chile



• Zaroxolyn
  Celltech, Hong Kong; Celltech, Israel; Orient Europharma, Taiwan; sanofi-aventis, Canada; Teofarma, Italy; UCB, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.